HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tert- butyloxycarbonyl- phenylalanyl- leucyl- phenylalanyl- leucyl- phenylalanyl- OH

Also Known As:

BOC-FLFLF; BOC-Phe(D)-Leu-Phe(D)-Leu-Phe-OH

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - tert-butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanyl-OH: 2

Experts

1.	Brack, Alexander: 1 article (04/2009)
2.	Hackel, Dagmar: 1 article (04/2009)
3.	Labuz, Dominika: 1 article (04/2009)
4.	Mousa, Shaaban: 1 article (04/2009)
5.	Rittner, Heike L: 1 article (04/2009)
6.	Schaefer, Michael: 1 article (04/2009)
7.	Schäfer, Michael: 1 article (04/2009)
8.	Stein, Christoph: 1 article (04/2009)
9.	Stolz, Andrea: 1 article (04/2009)
10.	Voigt, Philipp: 1 article (04/2009)

Related Diseases

1.	Pain (Aches) 04/01/2009 - "The FPR antagonists Boc-FLFLF and cyclosporine H reduced opioid peptide release in vitro and increased inflammatory pain in vivo while TLR 2/4 did not appear to be involved. "
2.	Alopecia (Baldness) 05/01/2007 - "The anti-alopecia effect of fMLP was not inhibited at all by Boc-FLFLF, a selective antagonist of formylpeptide receptor (FPR), which is the high affinity subtype of the fMLP receptor, but it was partly inhibited by Trp-Arg-Trp-Trp-Trp-Trp-NH(2) (WRW(4)), an antagonist of FPRL1 receptor. "

Related Drugs and Biologics

1.	Formyl Peptide Receptors (Formyl Peptide Receptor)
2.	Opioid Peptides (Opioid Peptide)
3.	human FPR2 protein
4.	cyclosporin H